NCT00013663View on ClinicalTrials.gov

Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load

PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2006

Conditions
HIV Infections
Interventions
BIOLOGICAL

ALVAC(2)120(B,MN)GNP (vCP1452)

DRUG

Aldesleukin

Trial Locations (1)

10021

New York Hosp - Cornell Med Ctr, New York

All Listed Sponsors
collaborator

New York Presbyterian Hospital

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00013663 - Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load | Biotech Hunter | Biotech Hunter